Dificid 200 MG tablet 20S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A0D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,067
Award facts
- Contract value 100% obligated
- $25,066.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $25,066.52, awards AmerisourceBergen Drug Corp the supply of Difici 200 mg tablets (20-count packages) for the Defense Logistics Agency (DLA). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and represents a non-set-aside competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026. This prime contract vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The DLA Troop Support Medical has indicated plans to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts through multiple awards to different regional contractors, demonstrating the strategic importance of pharmaceutical supply chain management across federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0A0D?
SPE2DR26F0A0D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F0A0D worth?
The government has obligated $25,067 on SPE2DR26F0A0D.
Is contract SPE2DR26F0A0D an order under another contract?
Yes. SPE2DR26F0A0D is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A0D competed?
The extent of competition for SPE2DR26F0A0D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award